Moreover, xanthine oxidase has been shown to mediate the oxidative stress induced by various anticancer compounds; for instance, pretreatment with allopurinol, a selective xanthine oxidase inhibitor, effectively prevented berberine-induced oxidative stress in human prostate cancer PC-3 cells [54]. This evidence concerns the gene XDH and prostate carcinoma.